References
- Wiznitzer M, Packer R J., August C S., Burkey E D. Neurological complications of bone marrow transplantation in childhood. Ann Neurol 1984; 16: 569–576
- Thompson C B., Sanders J E., Flournoy N, Buckner C D., Thomas E D. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood 1986; 67: 195–199
- Chessells J M., Cox T CS, Kendall B, Cavanagh N PC, Jannoun L, Richards S. Neurotoxicity in lymphoblastic leukemia: comparison of oral and intramuscular methotrexate and two doses of radiation. Arch Dis Child 1990; 65: 416–422
- Truwit C L., Denaro C P., Lake J R., DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR 1991; 12: 651–659
- Ellis W G., Sobel R A., Nielsen S L. Leukoencephalopathy in patients treated with amphotericin B methyl ester. J Infect Dis 1982; 146: 125–137
- Mulvihill J J. Clinical genetics of pediatric cancer. Principles and Practice of Pediatric Oncology, P A. Pizzo, D G. Poglack. Lippincott, Philadelphia 1989; 19–37
- Kemeny N, Younes A. Alfa-2a interferon and 5-fuorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience. Semin Oncol 1992; 19: 171–175
- Meyer C A., Scheibel R S., Forman A D. Persistent neurotoxicity of systemically administered in-terferon-alpha. Neurology 1991; 41: 672–676
- Meyer C A., Obbens E A., Scheibel R S., Moser R P. Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease. Cancer 1991; 68: 88–92
- Meyers J D., Flournoy N, Sanders J E., et al. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. Ann Intern Med 1987; 107: 809–816